NEPHROS INC
NEPHUS売上高
$19M
百万USD
営業利益
$1M
百万USD
純利益
$1M
百万USD
ROE
-
最新FY
EPS
$0.11
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $3M | $-1M | - |
| FY2021 | Q2 | $2M | $-1M | - |
| FY2021 | Q3 | $3M | $-1M | - |
| FY2021 | FY | $10M | $-4M | - |
| FY2022 | Q1 | $2M | $-2M | - |
| FY2022 | Q2 | $3M | $-1M | - |
| FY2022 | Q3 | $2M | $-3M | - |
| FY2022 | FY | $10M | - | - |
| FY2023 | Q1 | $4M | - | - |
| FY2023 | Q2 | $4M | - | $-0.04 |
| FY2023 | Q3 | $4M | - | $-0.02 |
| FY2023 | FY | $14M | - | $-0.15 |
| FY2024 | Q1 | $4M | $-0M | $-0.02 |
| FY2024 | Q2 | $3M | $-0M | $-0.03 |
| FY2024 | Q3 | $4M | $0M | $0.02 |
| FY2024 | FY | $14M | $0M | $0.01 |
| FY2025 | Q1 | $5M | $1M | $0.05 |
| FY2025 | Q2 | $4M | $0M | $0.02 |
| FY2025 | Q3 | $5M | $0M | $0.03 |
| FY2025 | FY | $19M | $1M | $0.11 |
| FY2026 | Q1 | $5M | $0M | $0.01 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $6M | $10M | $9M | $10M | $10M | $14M | $14M | $19M |
| 営業利益 | $-3M | $-2M | $-3M | $-3M | $-4M | $-4M | $-4M | $-2M | $0M | $1M |
| 純利益 | $-3M | $-1M | $-3M | $-3M | $-5M | $-4M | - | - | $0M | $1M |
| 総資産 | $3M | $5M | $11M | $12M | $19M | $18M | $11M | $12M | $11M | $14M |
| 純資産 | - | - | $7M | $8M | $16M | $15M | $9M | $8M | $9M | $10M |
| 自己資本 | $1M | $2M | $4M | $5M | $13M | $12M | $6M | $8M | - | - |
| 営業CF | - | - | $-4M | $-2M | $-7M | $-1M | $-3M | $1M | $-0M | $2M |
| EPS | - | - | - | - | - | - | - | $-0.15 | $0.01 | $0.11 |
| BPS | $0.01 | $0.03 | $0.06 | $0.52 | $1.26 | $1.14 | $0.53 | $0.79 | - | - |
| ROE | -454.6% | -41.5% | -89.6% | -73.2% | -36.1% | -33.1% | - | - | - | - |